Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

CRISPR and crRNAs02:53

CRISPR and crRNAs

18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K
The Antiviral System of Bacteria and Archaea: CRISPR01:23

The Antiviral System of Bacteria and Archaea: CRISPR

617
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
617
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

1.7K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.7K
CRISPR01:59

CRISPR

57.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.5K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

6.6K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.6K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Dexamethasone restores blood-brain barrier integrity in an in vitro heatstroke model.

PloS one·2026
Same author

Modeling Blood-Brain Barrier Efflux Transport Using a Breast Cancer Resistance Protein Overexpression Cell Line.

Biomedicines·2026
Same author

A controlled longitudinal study clarifies the contours of pediatric long COVID.

Pediatric research·2026
Same author

Placental Pathogens Associated With Adverse Maternal and Neonatal Outcomes.

Open forum infectious diseases·2026
Same author

A cross-strain CRISPRi sgRNA library for <i>Streptococcus agalactiae</i>.

Microbiology resource announcements·2026
Same author

Real-World Clinical Datasets in Practice: Applications for Learners, Clinician-Educators, and Health Services Teams.

Clinical and translational science·2026

Video Experimental Relacionado

Updated: Jan 15, 2026

Application of CRISPR Interference CRISPRi for Gene Silencing in Pathogenic Species of Leptospira
14:49

Application of CRISPR Interference CRISPRi for Gene Silencing in Pathogenic Species of Leptospira

Published on: August 14, 2021

5.6K

CRISPR interference en una cepa de Streptococcus agalactiae de tipo de secuencia multilocular 17

William D Cutts1, Aidan W Flanagan2, Brice K Gorman2

  • 1Department of Molecular and Cell Biology, University of Texas at Dallas, Dallas, Texas, USA.

Journal of bacteriology
|January 14, 2026
PubMed
Resumen

Los investigadores desarrollaron un sistema de interferencia CRISPR (CRISPRi) para estudiar la patogénesis del Estreptococo del Grupo B (GBS). Esta herramienta permite la reducción de genes dirigida en la cepa hipervirulenta ST-17 COH1, lo que ayuda a la investigación sobre la meningitis neonatal.

Palabras clave:
CRISPREstreptococo del Grupo B

Más Videos Relacionados

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins
10:46

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins

Published on: October 18, 2022

2.2K
Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein
05:48

Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein

Published on: March 16, 2022

3.0K

Videos de Experimentos Relacionados

Last Updated: Jan 15, 2026

Application of CRISPR Interference CRISPRi for Gene Silencing in Pathogenic Species of Leptospira
14:49

Application of CRISPR Interference CRISPRi for Gene Silencing in Pathogenic Species of Leptospira

Published on: August 14, 2021

5.6K
Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins
10:46

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins

Published on: October 18, 2022

2.2K
Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein
05:48

Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein

Published on: March 16, 2022

3.0K

Área de la Ciencia:

  • Microbiología
  • Genética
  • Enfermedades Infecciosas

Sus antecedentes:

  • El Estreptococo del Grupo B (GBS) es una causa principal de meningitis bacteriana neonatal.
  • La cepa hipervirulenta de serotipo III, tipo de secuencia 17 (ST-17) COH1 está relacionada con enfermedades graves, pero es genéticamente difícil de manipular.
  • La comprensión de los factores de virulencia de GBS en la barrera hematoencefálica (BHE) es crucial para combatir la meningitis neonatal.

Objetivo del estudio:

  • Desarrollar un sistema novedoso de interferencia CRISPR (CRISPRi) para la reducción de genes dirigida en la cepa GBS ST-17 COH1.
  • Permitir la genómica funcional y el cribado de alto rendimiento de los factores de virulencia de GBS.
  • Investigar las interacciones de GBS en la BHE.

Principales métodos:

  • Desarrollo de un sistema de interferencia CRISPR (CRISPRi) utilizando Cas9 catalíticamente inactivada (dCas9) en la cepa COH1.
  • Confirmación de la eficacia del sistema mediante ensayos de hemólisis y análisis de transcripción por qPCR.
  • Evaluación de los efectos de la reducción de genes in vitro utilizando modelos de infección de células endoteliales cerebrales humanas.

Principales resultados:

  • El sistema CRISPRi logró con éxito la reducción de la expresión génica sintonizable en GBS ST-17.
  • Se observaron reducciones fenotípicas de genes de virulencia clave (PI-2b, srr2, iagA).
  • Se demostró una reducción de la adhesión bacteriana, la invasión y las respuestas inflamatorias en la BHE.

Conclusiones:

  • La plataforma CRISPRi desarrollada proporciona una herramienta versátil para la manipulación genética en GBS ST-17.
  • Este sistema facilita la genómica funcional rápida y la investigación de la patogénesis de GBS.
  • Los hallazgos contribuyen a una mejor comprensión de la virulencia de GBS y las posibles dianas terapéuticas.